Related Experiment Videos
[Plasma fibronectin and alcoholic liver disease]
R Ricciardi1, G Restuccia, G Chindemi
1Istituto di patologia medica e medicina mediterranea, Università, Policlinico, Messina.
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio
|June 1, 1987
Summary
Monitoring plasma fibronectin in chronic alcoholics can help detect liver fibrosis. Elevated fibronectin levels correlate with advanced stages of alcoholic liver disease, indicating fibrosis progression.
Area of Science:
- Biochemistry
- Hepatology
- Clinical Diagnostics
Context:
- Chronic alcoholism is a leading cause of liver disease.
- Assessing liver damage progression in alcoholics is crucial for timely intervention.
- Existing biomarkers may not fully capture the spectrum of liver fibrosis.
Purpose:
- To investigate the utility of plasma fibronectin as a biomarker for liver fibrosis in chronic alcoholics.
- To correlate plasma fibronectin levels with different stages of alcoholic liver disease.
- To evaluate the relationship between fibronectin, SGPT, and albumin in this patient cohort.
Summary:
- Plasma fibronectin levels were significantly elevated in chronic alcoholics with steatofibrosis, evolutive chronic hepatitis, and cirrhosis.
- Unimportant changes in fibronectin were observed in simple steatosis.
- Elevated SGPT indicated cytolysis, while reduced albumin (except in decompensated cirrhosis) showed a negative correlation with fibronectin.
Impact:
- Plasma fibronectin monitoring may serve as a valuable tool for identifying and assessing liver fibrosis in chronic alcoholics.
- This finding could lead to earlier detection and management of liver damage.
- Further research could validate fibronectin as a non-invasive biomarker for liver fibrosis.